JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.77% |
| 2 | Technology | 12.5% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Corvus Pharmaceuticals
CRVS
$1.27B
| $2.52M | ﹤0.01% |
218,197
-27,264
| -11% | -$258K |
|
2952
Quanta Services
PWR
$101B
| $2.52M | ﹤0.01% |
73,224
-209,065
| -74% | -$7.58M |
|
|
ENLC
2953
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $2.52M | ﹤0.01% |
171,589
+111,147
| +184% | +$1.87M |
|
|
ETFC
2954
CALL
DELISTED
E*Trade Financial Corporation
ETFC
| $2.49M | ﹤0.01% |
45,000
-41,600
| -48% | -$2.22M |
|
2955
Healthcare Services Group
HCSG
$1.45B
| $2.49M | ﹤0.01% |
57,249
-51,452
| -47% | -$2.52M |
|
2956
CALL
Neurocrine Biosciences
NBIX
$15.3B
| $2.49M | ﹤0.01% |
+30,000
| New | +$2.53M |
|
|
2957
PUT
Neurocrine Biosciences
NBIX
$15.3B
| $2.49M | ﹤0.01% |
+30,000
| New | +$2.53M |
|
|
UBNK
2958
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.48M | ﹤0.01% |
153,364
-13,255
| -8% | -$220K |
|
2959
PUT
Trade Desk
TTD
$6.84B
| $2.48M | ﹤0.01% |
+500,000
| New | +$2.56M |
|
|
CRZO
2960
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $2.48M | ﹤0.01% |
155,099
-134,006
| -46% | -$2.52M |
|
2961
Invesco Large Cap Growth ETF
PWB
$2.45B
| $2.48M | ﹤0.01% |
57,964
-4,551
| -7% | -$198K |
|
2962
Howard Hughes
HHH
$4.04B
| $2.48M | ﹤0.01% |
18,688
-53,166
| -74% | -$6.52M |
|
|
BPMC
2963
CALL
DELISTED
Blueprint Medicines
BPMC
| $2.48M | ﹤0.01% |
+27,000
| New | +$2.33M |
|
|
BPMC
2964
PUT
DELISTED
Blueprint Medicines
BPMC
| $2.48M | ﹤0.01% |
+27,000
| New | +$2.33M |
|
2965
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.98B
| $2.47M | ﹤0.01% |
87,626
+20,072
| +30% | +$590K |
|
|
XYZ
2966
CALL
Block Inc
XYZ
$49.9B
| $2.46M | ﹤0.01% |
+50,000
| New | +$2.29M |
|
|
BRKL
2967
DELISTED
Brookline Bancorp
BRKL
| $2.46M | ﹤0.01% |
151,661
-27,075
| -15% | -$443K |
|
|
CWEN.A
2968
DELISTED
Clearway Energy Class A
CWEN.A
| $2.45M | ﹤0.01% |
148,855
-36,646
| -20% | -$634K |
|
2969
Townsquare Media
TSQ
$104M
| $2.44M | ﹤0.01% |
308,135
+6,448
| +2% | +$47.4K |
|
2970
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $2.44M | ﹤0.01% |
68,758
+52,657
| +327% | +$1.85M |
|
|
PGNX
2971
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.44M | ﹤0.01% |
326,562
+237,992
| +269% | +$1.58M |
|
2972
WisdomTree Europe SmallCap Dividend Fund
DFE
$169M
| $2.43M | ﹤0.01% |
34,808
+29,418
| +546% | +$2.11M |
|
|
ATRI
2973
DELISTED
Atrion Corp
ATRI
| $2.43M | ﹤0.01% |
3,848
-688
| -15% | -$403K |
|
2974
Scansource
SCSC
$1.06B
| $2.42M | ﹤0.01% |
68,071
+3,638
| +6% | +$124K |
|
|
SVM
2975
Silvercorp Metals
SVM
$2.61B
| $2.42M | ﹤0.01% |
899,124
+50,400
| +6% | +$133K |
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,570 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.